These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17785018)

  • 61. [Metabolic changes in PI-based HAART. Change to atazanavir: continued effectiveness with improved lipid profile].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():42-3. PubMed ID: 19024917
    [No Abstract]   [Full Text] [Related]  

  • 62. 96-week data from CASTLE study presented.
    Proj Inf Perspect; 2008 Dec; (47):3-4. PubMed ID: 19230058
    [No Abstract]   [Full Text] [Related]  

  • 63. The HIV-1 protease resistance mutation I50L is associated with resistance to atazanavir and susceptibility to other protease inhibitors in multiple mutational contexts.
    Sista P; Wasikowski B; Lecocq P; Pattery T; Bacheler L
    J Clin Virol; 2008 Aug; 42(4):405-8. PubMed ID: 18472298
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CASTLE analysis finds no benefit for once daily dosing.
    Proj Inf Perspect; 2008 Dec; (47):4. PubMed ID: 19226675
    [No Abstract]   [Full Text] [Related]  

  • 65. Reyataz monotherapy study stopped.
    Proj Inf Perspect; 2007 Oct; (44):23-4. PubMed ID: 18046835
    [No Abstract]   [Full Text] [Related]  

  • 66. Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice.
    Moltó J; Santos JR; Valle M; Miranda C; Miranda J; Blanco A; Negredo E; Clotet B
    Ther Drug Monit; 2007 Oct; 29(5):648-51. PubMed ID: 17898658
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes.
    Jones SP; Waitt C; Sutton R; Back DJ; Pirmohamed M
    AIDS; 2008 Jul; 22(11):1293-8. PubMed ID: 18580608
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.
    Solas C; Gagnieu MC; Ravaux I; Drogoul MP; Lafeuillade A; Mokhtari S; Lacarelle B; Simon N
    Ther Drug Monit; 2008 Dec; 30(6):670-3. PubMed ID: 18806695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Carotid plaque caused by usual risk factors.
    AIDS Patient Care STDS; 2005 Sep; 19(9):616. PubMed ID: 16245409
    [No Abstract]   [Full Text] [Related]  

  • 71. HIV protease inhibitors and hyperlipidemia: a fatty acid connection.
    Spector AA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):7-9. PubMed ID: 16373621
    [No Abstract]   [Full Text] [Related]  

  • 72. Can nifedipine provoke menorrhagia?
    Rodger JC; Torrance TC
    Lancet; 1983 Aug; 2(8347):460. PubMed ID: 6135947
    [No Abstract]   [Full Text] [Related]  

  • 73. Beyond blood pressure: subtle effects of drug classes.
    O'Rourke MF
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2238-9. PubMed ID: 16258148
    [No Abstract]   [Full Text] [Related]  

  • 74. Reyataz may cause EKG abnormality.
    AIDS Patient Care STDS; 2004 Dec; 18(12):737. PubMed ID: 15669126
    [No Abstract]   [Full Text] [Related]  

  • 75. [Hypermenorrhea caused by flunarizine].
    Rodríguez Moreno C; Vidal Oliveras A; Vallano Ferraz A
    Med Clin (Barc); 1991 Jan; 96(3):116. PubMed ID: 2033975
    [No Abstract]   [Full Text] [Related]  

  • 76. Surreptitious ingestion of warfarin.
    Maharaj D; Walker ID; Paice B; Lawson DH
    Practitioner; 1986 Feb; 230(1412):105-8. PubMed ID: 3703807
    [No Abstract]   [Full Text] [Related]  

  • 77. Atazanavir-associated menorrhagia.
    Paparizos VA; Kourkounti S; Leuow K; Kyriakis KP; Botsi C; Katsambas AD
    Int J STD AIDS; 2007 Sep; 18(9):651-2. PubMed ID: 17785018
    [No Abstract]   [Full Text] [Related]  

  • 78. Atazanavir urinary stones in an HIV-infected patient.
    Pacanowski J; Poirier JM; Petit I; Meynard JL; Girard PM
    AIDS; 2006 Oct; 20(16):2131. PubMed ID: 17053366
    [No Abstract]   [Full Text] [Related]  

  • 79. Urolithiasis in HIV-positive patients treated with atazanavir.
    Couzigou C; Daudon M; Meynard JL; Borsa-Lebas F; Higueret D; Escaut L; Zucman D; Liotier JY; Quencez JL; Asselah K; May T; Neau D; Vittecoq D
    Clin Infect Dis; 2007 Oct; 45(8):e105-8. PubMed ID: 17879904
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alopecia associated with ritonavir-boosted atazanavir therapy.
    Torres HA; Barnett BJ; Arduino RC
    AIDS; 2007 Jun; 21(10):1391-2. PubMed ID: 17545728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.